menu
    • menu

    Company profile for MedinCell

    NEW Drugs in Dev: 5
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. c...
    MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MedinCellFrance Flag
    Country
    Country
    France
    Address
    Address
    3 rue des Frères Lumière, Jacou, Occitanie 34830, FR
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://invest.medincell.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/medincell/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/medincell

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medincell to Publish Annual Financial Results on June 16
    Medincell to Publish Annual Financial Results on June 16

    28 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260528020839/en/Medincell-Videoconference-and-Publication-of-Annual-Financial-Results-Tuesday-June-16-2026

    BUSINESSWIRE
    28 May 2026
    Share Share
    Medincell to Join Jefferies & Evercore Investor Conferences
    Medincell to Join Jefferies & Evercore Investor Conferences

    26 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-26/medincell-to-participate-in-jefferies-and-evercore-investor-conferences-in-the-us-in-june

    PHARMIWEB
    26 May 2026
    Share Share
    EMA Accepts Teva Application for Olanzapine LAI in Schizophrenia
    EMA Accepts Teva Application for Olanzapine LAI in Schizophrenia

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299597/0/en/the-european-medicines-agency-accepts-teva-s-marketing-authorization-application-for-olanzapine-long-acting-injectable-tev-749-for-the-treatment-of-schizophrenia-in-adults.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Degroof Petercam Initiates Medincell Coverage With Buy Rating
    Degroof Petercam Initiates Medincell Coverage With Buy Rating

    22 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-22/degroof-petercam-initiates-medincell-s-coverage-with-a-buy-recommendation

    PHARMIWEB
    22 Apr 2026
    Share Share
    Leerink Partners Initiates Medincell Coverage With Outperform
    Leerink Partners Initiates Medincell Coverage With Outperform

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/leerink-partners-initiates-medincell-s-coverage-with-a-outperform-recommendation

    PHARMIWEB
    21 Apr 2026
    Share Share
    EIB Waives Its Right To Cash Settlement On Medincell Warrants
    EIB Waives Its Right To Cash Settlement On Medincell Warrants

    26 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-26/eib-waives-its-right-to-cash-settlement-on-medincell-warrants

    PHARMIWEB
    26 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search